Title of Collaborative Activity: |
NIDA-FDA Interagency Clinical Outcomes Assessment Working Group (ICOAWG) |
Description of Collaborative Activity: |
The Interagency Clinical Outcomes Assessment Working Group (ICOAWG) facilitates scientific exchange between the National Institutes of Health (NIH) and Federal Drug Administration (FDA) and helps to guide research and stay abreast of new and ongoing clinical trials and measurement approaches being used. There is a focus on standards and use of Clinical Outcome Assessments. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
|
NIH Participating Institutes/Centers/Office of the Director: |
NIDA, NCI, OD/DPCPSI/OBSSR |
HHS Agency Collaborators on this Activity: |
FDA |
